From January 1, 2023 to March 31, 2023, the company has repurchased 347,200 shares, representing 0.04% for CNY 13.7 million. With this, the company has completed the repurchase of 1,604,500 shares, representing 0.19% for CNY 61 million under the buyback announced on September 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.22 CNY | -1.55% | -4.40% | -37.13% |
05-23 | Jiuzhou Pharmaceutical Plans CRO in Germany | MT |
04-24 | Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.13% | 1.89B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on September 1, 2022.